Logo 1 Logo 2

Clinical Trial Details

Trial ID: L4033
Source ID: NCT01720446
Associated Drug: Semaglutide
Title: Trial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide in Subjects With Type 2 Diabetes
Acronym: SUSTAIN™ 6
Status: COMPLETED
Study Results: YES
Results: https://ClinicalTrials.gov/show/NCT01720446/results
Conditions: Diabetes|Diabetes Mellitus, Type 2
Interventions: DRUG: semaglutide|DRUG: semaglutide|DRUG: placebo
Outcome Measures: Primary: Time From Randomisation to First Occurrence of a MACE, Defined as Cardiovascular Death, Non-fatal Myocardial Infarction, or Non-fatal Stroke, Percentage of subjects experiencing a first event of a major adverse cardiovascular event (MACE), defined as cardiovascular (CV) death, non-fatal myocardial infarction (MI), or non-fatal stroke., Time from randomisation up to end of follow-up (scheduled at week 109) | Secondary: Time From Randomisation to First Occurrence of an Expanded Composite Cardiovascular Outcome, Percentage of subjects experiencing first occurrence of an expanded composite CV outcome (defined as either MACE, revascularisation \[coronary and peripheral\], unstable angina requiring hospitalisation or hospitalisation for heart failure), Time from randomisation up to end of follow-up (scheduled at week 109)|Time From Randomisation to Each Individual Component of the Expanded Composite Cardiovascular Outcome, Percentage of subjects experiencing an event onset for each individual component of the expanded composite cardiovascular outcomes (defined as either MACE, revascularisation \[coronary and peripheral\], unstable angina requiring hospitalisation or hospitalisation for heart failure)., Time from randomisation up to end of follow-up (scheduled at week 109)|Time From Randomisation to First Occurrence of All-cause Death, Non-fatal MI, or Non-fatal Stroke, Percentage of subjects experiencing a first occurrence of all-cause death, non-fatal MI, or non-fatal stroke., Time from randomisation up to end of follow-up (scheduled at week 109)|Change From Baseline to Last Assessment in the Trial in Other Treatment Outcomes: Glycosylated Haemoglobin (HbA1c), Estimated mean change from baseline in glycosylated haemoglobin (HbA1c) to last assessment in the trial during the treatment period., Week 0, up to week 104|Change From Baseline to Last Assessment in the Trial in Other Treatment Outcomes: Fasting Plasma Glucose, Estimated mean change from baseline to last assessment in fasting plasma glucose in the trial during the treatment period., Week 0, up to week 104|Change From Baseline to Last Assessment in the Trial in Other Treatment Outcomes: Body Weight, Estimated mean change from baseline to last assessment in body weight in the trial during the treatment period., Week 0, up to week 104|Change From Baseline to Last Assessment in the Trial in Other Treatment Outcomes: Lipid Profile, Estimated ratio to baseline at week 104 during the treatment period in lipid profile (total cholesterol, HDL cholesterol, LDL cholesterol and triglycerides)., Week 0, up to week 104|Change From Baseline to Last Assessment in the Trial in Other Treatment Outcomes: Urinary Albumin to Creatinine Ratio, Estimated ratio to baseline in urinary albumin to creatinine ratio at week 104 during the treatment period., Week 0, up to week 104|Change From Baseline to Last Assessment in the Trial in Other Treatment Outcomes: Vital Signs, Estimated mean change from baseline to last assessment in the trial during the treatment period in vital signs (diastolic blood pressure and systolic blood pressure)., Week 0, up to week 104|Incidence During the Trial in Other Treatment Outcomes: Hypoglycaemic Events, Rates (event rate per 100 exposure years) of severe or blood glucose confirmed symptomatic hypoglycaemia defned as an episode that was severe according to the American diabetic association (ADA) classification or blood glucose (BG) confirmed by a PG value \<3.1 mmol/L (56 mg/dL) with symptoms consistent with hypoglycaemia., Week 0 - 109|Incidence During the Trial in Other Treatment Outcomes: Adverse Events, Rates (event rate per 100 years of exposure) of treatment emergent adverse events., Weeks 0-109|Occurrence During the Trial in Other Treatment Outcomes: Anti-semaglutide Antibodies, The percentage of subjects that tested positive for anti-semaglutide antibodies at any time point post-baseline during the trial, from week 0 to week 109., Weeks 0-109|Change From Baseline to Last Assessment in the Trial in Other Treatment Outcomes: Patient Reported Outcome (PRO), Estimated mean change from baseline to last assessment in the trial in patient reported outcomes (PRO). PRO questionnaire (SF-36v2TM) measured the individual overall health related quality of life namely bodily pain, general health, mental component summary, mental health, physical component summary, physical functioning, role-emotional, role-physical, social functioning and vitality. The PRO scores were transformed to a 0-100 scale with higher scores indicating greater health related quality of life., Week 0, up to week 104|Change From Baseline to Last Assessment in the Trial in Other Treatment Outcomes: Lipid Profile (Free Fatty Acids), Estimated ratio to baseline at week 104 during the treatment period in lipid profile (free fatty acids)., Week 0, up to week 104|Change From Baseline to Last Assessment in the Trial in Other Treatment Outcomes: Vital Signs (Pulse Rate), Estimated mean change from baseline to last assessment in the trial during the treatment period in vital signs (pulse rate)., Week 0, up to week 104
Sponsor/Collaborators: Sponsor: Novo Nordisk A/S
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE3
Enrollment: 3297
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Start Date: 2013-02-21
Completion Date: 2016-03-15
Results First Posted: 2018-03-15
Last Update Posted: 2019-06-27
Locations: Novo Nordisk Investigational Site, Birmingham, Alabama, 35205-4731, United States|Novo Nordisk Investigational Site, Birmingham, Alabama, 35216, United States|Novo Nordisk Investigational Site, Chandler, Arizona, 85224, United States|Novo Nordisk Investigational Site, Anaheim, California, 92801, United States|Novo Nordisk Investigational Site, Greenbrae, California, 94904, United States|Novo Nordisk Investigational Site, Lancaster, California, 93534, United States|Novo Nordisk Investigational Site, Los Angeles, California, 90017-4006, United States|Novo Nordisk Investigational Site, Mission Hills, California, 91345, United States|Novo Nordisk Investigational Site, Monterey, California, 93940, United States|Novo Nordisk Investigational Site, Northridge, California, 91325, United States|Novo Nordisk Investigational Site, San Diego, California, 92108, United States|Novo Nordisk Investigational Site, San Ramon, California, 94583, United States|Novo Nordisk Investigational Site, Ventura, California, 93003, United States|Novo Nordisk Investigational Site, Aurora, Colorado, 80045, United States|Novo Nordisk Investigational Site, Waterbury, Connecticut, 06708, United States|Novo Nordisk Investigational Site, Bradenton, Florida, 34201, United States|Novo Nordisk Investigational Site, Crystal River, Florida, 34429, United States|Novo Nordisk Investigational Site, DeLand, Florida, 32724, United States|Novo Nordisk Investigational Site, Jacksonville, Florida, 32216, United States|Novo Nordisk Investigational Site, Melbourne, Florida, 32901, United States|Novo Nordisk Investigational Site, Melbourne, Florida, 32934, United States|Novo Nordisk Investigational Site, Ocala, Florida, 34470, United States|Novo Nordisk Investigational Site, Ponte Vedra, Florida, 32081, United States|Novo Nordisk Investigational Site, Saint Petersburg, Florida, 33707, United States|Novo Nordisk Investigational Site, Spring Hill, Florida, 34609, United States|Novo Nordisk Investigational Site, Dunwoody, Georgia, 30338, United States|Novo Nordisk Investigational Site, Lawrenceville, Georgia, 30046, United States|Novo Nordisk Investigational Site, Chicago, Illinois, 60607, United States|Novo Nordisk Investigational Site, Crystal Lake, Illinois, 60012, United States|Novo Nordisk Investigational Site, Gurnee, Illinois, 60031, United States|Novo Nordisk Investigational Site, Michigan City, Indiana, 46360, United States|Novo Nordisk Investigational Site, Mishawaka, Indiana, 46544, United States|Novo Nordisk Investigational Site, Wichita, Kansas, 67205, United States|Novo Nordisk Investigational Site, Louisville, Kentucky, 40206, United States|Novo Nordisk Investigational Site, Louisville, Kentucky, 40213, United States|Novo Nordisk Investigational Site, Monroe, Louisiana, 71203, United States|Novo Nordisk Investigational Site, New Orleans, Louisiana, 70112, United States|Novo Nordisk Investigational Site, Methuen, Massachusetts, 01844, United States|Novo Nordisk Investigational Site, North Dartmouth, Massachusetts, 02747, United States|Novo Nordisk Investigational Site, Kalamazoo, Michigan, 49048, United States|Novo Nordisk Investigational Site, Chesterfield, Missouri, 63017, United States|Novo Nordisk Investigational Site, Kansas City, Missouri, 64111, United States|Novo Nordisk Investigational Site, Saint Louis, Missouri, 63128, United States|Novo Nordisk Investigational Site, Saint Louis, Missouri, 63141, United States|Novo Nordisk Investigational Site, Omaha, Nebraska, 68114, United States|Novo Nordisk Investigational Site, Omaha, Nebraska, 68198-3020, United States|Novo Nordisk Investigational Site, Lebanon, New Hampshire, 03756, United States|Novo Nordisk Investigational Site, Nashua, New Hampshire, 03063, United States|Novo Nordisk Investigational Site, Mine Hill, New Jersey, 07803, United States|Novo Nordisk Investigational Site, Toms River, New Jersey, 08755-8050, United States|Novo Nordisk Investigational Site, Albany, New York, 12206, United States|Novo Nordisk Investigational Site, New York, New York, 10001, United States|Novo Nordisk Investigational Site, Rochester, New York, 14609, United States|Novo Nordisk Investigational Site, Staten Island, New York, 10301, United States|Novo Nordisk Investigational Site, West Seneca, New York, 14224, United States|Novo Nordisk Investigational Site, Asheboro, North Carolina, 27203, United States|Novo Nordisk Investigational Site, Asheville, North Carolina, 28801, United States|Novo Nordisk Investigational Site, Chapel Hill, North Carolina, 27517, United States|Novo Nordisk Investigational Site, Greenville, North Carolina, 27834, United States|Novo Nordisk Investigational Site, Raleigh, North Carolina, 27612, United States|Novo Nordisk Investigational Site, Whiteville, North Carolina, 28472, United States|Novo Nordisk Investigational Site, Wilmington, North Carolina, 28401, United States|Novo Nordisk Investigational Site, Cincinnati, Ohio, 45219, United States|Novo Nordisk Investigational Site, Cleveland, Ohio, 44106, United States|Novo Nordisk Investigational Site, Franklin, Ohio, 45005, United States|Novo Nordisk Investigational Site, Mason, Ohio, 45040-6815, United States|Novo Nordisk Investigational Site, Maumee, Ohio, 43537, United States|Novo Nordisk Investigational Site, Oklahoma City, Oklahoma, 73104, United States|Novo Nordisk Investigational Site, Beaver, Pennsylvania, 15009-1957, United States|Novo Nordisk Investigational Site, McMurray, Pennsylvania, 15317, United States|Novo Nordisk Investigational Site, Philadelphia, Pennsylvania, 19114, United States|Novo Nordisk Investigational Site, Greer, South Carolina, 29651, United States|Novo Nordisk Investigational Site, Myrtle Beach, South Carolina, 29572, United States|Novo Nordisk Investigational Site, Bartlett, Tennessee, 38133, United States|Novo Nordisk Investigational Site, Kingsport, Tennessee, 37660, United States|Novo Nordisk Investigational Site, Memphis, Tennessee, 38163, United States|Novo Nordisk Investigational Site, Nashville, Tennessee, 37212, United States|Novo Nordisk Investigational Site, Dallas, Texas, 75218, United States|Novo Nordisk Investigational Site, Dallas, Texas, 75230, United States|Novo Nordisk Investigational Site, Dallas, Texas, 75231, United States|Novo Nordisk Investigational Site, Dallas, Texas, 75390-9302, United States|Novo Nordisk Investigational Site, Fort Worth, Texas, 76132, United States|Novo Nordisk Investigational Site, Houston, Texas, 77074, United States|Novo Nordisk Investigational Site, Irving, Texas, 75061-2210, United States|Novo Nordisk Investigational Site, Longview, Texas, 75605, United States|Novo Nordisk Investigational Site, Odessa, Texas, 79761, United States|Novo Nordisk Investigational Site, Plano, Texas, 75075, United States|Novo Nordisk Investigational Site, San Antonio, Texas, 78224, United States|Novo Nordisk Investigational Site, San Antonio, Texas, 78228-3419, United States|Novo Nordisk Investigational Site, Sugar Land, Texas, 77478, United States|Novo Nordisk Investigational Site, Salt Lake City, Utah, 84107, United States|Novo Nordisk Investigational Site, South Burlington, Vermont, 05403-7205, United States|Novo Nordisk Investigational Site, Richmond, Virginia, 23219, United States|Novo Nordisk Investigational Site, Winchester, Virginia, 22601-3834, United States|Novo Nordisk Investigational Site, Winchester, Virginia, 22601, United States|Novo Nordisk Investigational Site, Wenatchee, Washington, 98801-2028, United States|Novo Nordisk Investigational Site, Madison, Wisconsin, 53792, United States|Novo Nordisk Investigational Site, Annaba, 23000, Algeria|Novo Nordisk Investigational Site, Oran, 31000, Algeria|Novo Nordisk Investigational Site, Setif, 19000, Algeria|Novo Nordisk Investigational Site, Tizi Ouzou, 15000, Algeria|Novo Nordisk Investigational Site, Caba, C1093AAS, Argentina|Novo Nordisk Investigational Site, Caba, C1180AAX, Argentina|Novo Nordisk Investigational Site, Caba, C1440AAD, Argentina|Novo Nordisk Investigational Site, Caba, Argentina|Novo Nordisk Investigational Site, Cordoba, 5000, Argentina|Novo Nordisk Investigational Site, Mar del Plata, B7600FZN, Argentina|Novo Nordisk Investigational Site, Morón, B1708IFF, Argentina|Novo Nordisk Investigational Site, Blacktown, New South Wales, 2148, Australia|Novo Nordisk Investigational Site, St Leonards, New South Wales, 2065, Australia|Novo Nordisk Investigational Site, Ipswich, Queensland, 4305, Australia|Novo Nordisk Investigational Site, Keswick, South Australia, 5035, Australia|Novo Nordisk Investigational Site, Oaklands Park, South Australia, 5046, Australia|Novo Nordisk Investigational Site, Box Hill, Victoria, 3128, Australia|Novo Nordisk Investigational Site, Fitzroy, Victoria, 3065, Australia|Novo Nordisk Investigational Site, Fremantle, Western Australia, 6160, Australia|Novo Nordisk Investigational Site, Curitiba, Parana, 80030-110, Brazil|Novo Nordisk Investigational Site, Belém, Para, 66073-000, Brazil|Novo Nordisk Investigational Site, Campinas, Sao Paulo, 13059-740, Brazil|Novo Nordisk Investigational Site, São Paulo, Sao Paulo, 01228-000, Brazil|Novo Nordisk Investigational Site, São Paulo, Sao Paulo, 01228-200, Brazil|Novo Nordisk Investigational Site, São Paulo, Sao Paulo, 04038-002, Brazil|Novo Nordisk Investigational Site, São Paulo, Sao Paulo, 05403-000, Brazil|Novo Nordisk Investigational Site, Porto Alegre, 90035-170, Brazil|Novo Nordisk Investigational Site, Pleven, 5800, Bulgaria|Novo Nordisk Investigational Site, Sofia, 1324, Bulgaria|Novo Nordisk Investigational Site, Sofia, 1606, Bulgaria|Novo Nordisk Investigational Site, Varna, 9010, Bulgaria|Novo Nordisk Investigational Site, Calgary, Alberta, T2V 4J2, Canada|Novo Nordisk Investigational Site, Edmonton, Alberta, T6G 2E1, Canada|Novo Nordisk Investigational Site, Winnipeg, Manitoba, R3E 3P4, Canada|Novo Nordisk Investigational Site, St. John's, Newfoundland and Labrador, A1E 2C2, Canada|Novo Nordisk Investigational Site, Cambridge, Ontario, N1R 7L6, Canada|Novo Nordisk Investigational Site, Cornwall, Ontario, K6H 4M4, Canada|Novo Nordisk Investigational Site, London, Ontario, N6A 4V2, Canada|Novo Nordisk Investigational Site, Smiths Falls, Ontario, K7A 4W8, Canada|Novo Nordisk Investigational Site, Toronto, Ontario, M5C 2T2, Canada|Novo Nordisk Investigational Site, Waterloo, Ontario, N2J 1C4, Canada|Novo Nordisk Investigational Site, Drummondville, Quebec, J2B 7T1, Canada|Novo Nordisk Investigational Site, Montreal, Quebec, H4A 3T2, Canada|Novo Nordisk Investigational Site, Victoriaville, Quebec, G6P 6P6, Canada|Novo Nordisk Investigational Site, Quebec, G1V 4G5, Canada|Novo Nordisk Investigational Site, Aarhus C, 8000, Denmark|Novo Nordisk Investigational Site, Gentofte, 2820, Denmark|Novo Nordisk Investigational Site, Hellerup, 2900, Denmark|Novo Nordisk Investigational Site, Hvidovre, 2650, Denmark|Novo Nordisk Investigational Site, Odense, 5000, Denmark|Novo Nordisk Investigational Site, Elsterwerda, 04910, Germany|Novo Nordisk Investigational Site, Essen, 45219, Germany|Novo Nordisk Investigational Site, Falkensee, 14612, Germany|Novo Nordisk Investigational Site, Freiburg, 79106, Germany|Novo Nordisk Investigational Site, Hamburg, 22607, Germany|Novo Nordisk Investigational Site, Münster, 48145, Germany|Novo Nordisk Investigational Site, Oldenburg, 23758, Germany|Novo Nordisk Investigational Site, Saint Ingbert, 66386, Germany|Novo Nordisk Investigational Site, Hyderabad, Andhra Pradesh, 500003, India|Novo Nordisk Investigational Site, Hyderabad, Andhra Pradesh, 500034, India|Novo Nordisk Investigational Site, Hyderabad, Andhra Pradesh, 500082, India|Novo Nordisk Investigational Site, Visakhapatnam, Andhra Pradesh, 530002, India|Novo Nordisk Investigational Site, Bangalore, Karnataka, 560034, India|Novo Nordisk Investigational Site, Mysore, Karnataka, 570001, India|Novo Nordisk Investigational Site, Kochi, Kerala, 682041, India|Novo Nordisk Investigational Site, Mumbai, Maharashtra, 400008, India|Novo Nordisk Investigational Site, Mumbai, Maharashtra, 400010, India|Novo Nordisk Investigational Site, Mumbai, Maharashtra, 400012, India|Novo Nordisk Investigational Site, Mumbai, Maharashtra, 400016, India|Novo Nordisk Investigational Site, Mumbai, Maharashtra, 400022, India|Novo Nordisk Investigational Site, Delhi, New Delhi, 110002, India|Novo Nordisk Investigational Site, New Dehli, New Delhi, 110029, India|Novo Nordisk Investigational Site, Chandigarh, Punjab, 160012, India|Novo Nordisk Investigational Site, Chennai, Tamil Nadu, 600086, India|Novo Nordisk Investigational Site, Vellore, Tamil Nadu, 632004, India|Novo Nordisk Investigational Site, Kolkata, West Bengal, 700032, India|Novo Nordisk Investigational Site, Kolkata, West Bengal, 700054, India|Novo Nordisk Investigational Site, New Delhi, 110095, India|Novo Nordisk Investigational Site, Pune, 411011, India|Novo Nordisk Investigational Site, Holon, 58100, Israel|Novo Nordisk Investigational Site, Jerusalem, 91120, Israel|Novo Nordisk Investigational Site, Nahariya, 22100, Israel|Novo Nordisk Investigational Site, Petah-Tikva, 49100, Israel|Novo Nordisk Investigational Site, Tel Hashomer, 52621, Israel|Novo Nordisk Investigational Site, Tel-Aviv, 64239, Israel|Novo Nordisk Investigational Site, Bergamo, 24127, Italy|Novo Nordisk Investigational Site, Chieti, 66100, Italy|Novo Nordisk Investigational Site, Olbia, 07026, Italy|Novo Nordisk Investigational Site, Padova, 35128, Italy|Novo Nordisk Investigational Site, Primo Piano Palazzina Ambulato, 40133, Italy|Novo Nordisk Investigational Site, Siena, 53100, Italy|Novo Nordisk Investigational Site, Kota Samarahan, 94300, Malaysia|Novo Nordisk Investigational Site, Kuala Lumpur, 59100, Malaysia|Novo Nordisk Investigational Site, Kuching, 93586, Malaysia|Novo Nordisk Investigational Site, Melaka, 75400, Malaysia|Novo Nordisk Investigational Site, Serdang, 43000, Malaysia|Novo Nordisk Investigational Site, Seremban, 70300, Malaysia|Novo Nordisk Investigational Site, Guadalajara, Jalisco, 44130, Mexico|Novo Nordisk Investigational Site, Guadalajara, Jalisco, 44600, Mexico|Novo Nordisk Investigational Site, Guadalajara, Jalisco, 44670, Mexico|Novo Nordisk Investigational Site, Cuernavaca, Morelos, 62250, Mexico|Novo Nordisk Investigational Site, Mexico City, México, D.F., 03300, Mexico|Novo Nordisk Investigational Site, Mexico City, México, D.F., 14000, Mexico|Novo Nordisk Investigational Site, México D.F., México, D.F., 11550, Mexico|Novo Nordisk Investigational Site, Ciudad Madero, Tamaulipas, 89440, Mexico|Novo Nordisk Investigational Site, Aguascalientes, 20230, Mexico|Novo Nordisk Investigational Site, San Luis Potosi, 78200, Mexico|Novo Nordisk Investigational Site, Bialystok, 15-445, Poland|Novo Nordisk Investigational Site, Gdansk, 80-858, Poland|Novo Nordisk Investigational Site, Lublin, 20-044, Poland|Novo Nordisk Investigational Site, Warszawa, 01-192, Poland|Novo Nordisk Investigational Site, Zabrze, 41-800, Poland|Novo Nordisk Investigational Site, Arkhangelsk, 163001, Russian Federation|Novo Nordisk Investigational Site, Arkhangelsk, 163045, Russian Federation|Novo Nordisk Investigational Site, Barnaul, 656045, Russian Federation|Novo Nordisk Investigational Site, Kazan, 420043, Russian Federation|Novo Nordisk Investigational Site, Moscow, 117997, Russian Federation|Novo Nordisk Investigational Site, Moscow, 119435, Russian Federation|Novo Nordisk Investigational Site, Novosibirsk, 630047, Russian Federation|Novo Nordisk Investigational Site, Penza, 440026, Russian Federation|Novo Nordisk Investigational Site, Saint-Petersburg, 199034, Russian Federation|Novo Nordisk Investigational Site, Saratov, 410031, Russian Federation|Novo Nordisk Investigational Site, Saratov, 410053, Russian Federation|Novo Nordisk Investigational Site, Smolensk, 214019, Russian Federation|Novo Nordisk Investigational Site, Yaroslavl, 150062, Russian Federation|Novo Nordisk Investigational Site, Almería, 04001, Spain|Novo Nordisk Investigational Site, Antequera, 29200, Spain|Novo Nordisk Investigational Site, Pozuelo de Alarcon, 28223, Spain|Novo Nordisk Investigational Site, Sanlúcar De Barrameda - Cádiz-, 15540, Spain|Novo Nordisk Investigational Site, Sevilla, 41010, Spain|Novo Nordisk Investigational Site, Vic (Barcelona), 08500, Spain|Novo Nordisk Investigational Site, Chiayi City, 600, Taiwan|Novo Nordisk Investigational Site, Tainan city, 710, Taiwan|Novo Nordisk Investigational Site, Taipei, 114, Taiwan|Novo Nordisk Investigational Site, Taoyuan, 333, Taiwan|Novo Nordisk Investigational Site, Bangkok, 10330, Thailand|Novo Nordisk Investigational Site, Bangkok, 10400, Thailand|Novo Nordisk Investigational Site, Bangkok, 10700, Thailand|Novo Nordisk Investigational Site, Ankara, 06100, Turkey|Novo Nordisk Investigational Site, Ankara, 06110, Turkey|Novo Nordisk Investigational Site, Antalya, 07058, Turkey|Novo Nordisk Investigational Site, Canakkale, 17020, Turkey|Novo Nordisk Investigational Site, Denizli, 20070, Turkey|Novo Nordisk Investigational Site, Istanbul, 34096, Turkey|Novo Nordisk Investigational Site, Istanbul, 34722, Turkey|Novo Nordisk Investigational Site, Istanbul, 34890, Turkey|Novo Nordisk Investigational Site, Izmir, 35340, Turkey|Novo Nordisk Investigational Site, Kocaeli, 41380, Turkey|Novo Nordisk Investigational Site, Aberdeen, AB25 2ZD, United Kingdom|Novo Nordisk Investigational Site, Birmingham, B9 5SS, United Kingdom|Novo Nordisk Investigational Site, Leeds, LS25 1AN, United Kingdom|Novo Nordisk Investigational Site, Liverpool, L9 7AL, United Kingdom|Novo Nordisk Investigational Site, Northwood, HA6 2RN, United Kingdom|Novo Nordisk Investigational Site, Sidcup, DA14 6LT, United Kingdom|Novo Nordisk Investigational Site, Swansea, SA6 6NL, United Kingdom|Novo Nordisk Investigational Site, Torquay, TQ2 7AA, United Kingdom
URL: https://clinicaltrials.gov/show/NCT01720446

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress